After you’re diagnosed with a hereditary condition or receive positive results from genetic testing, a series of practical steps follows: updated screening schedules, conversations with family members, decisions about preventive care, and adjustments to insurance and family planning. The process can feel overwhelming, but each step has a clear purpose and timeline.
Understanding Your Results
Genetic test results fall into a few categories, and the one you receive shapes everything that comes next. A positive result (called pathogenic or likely pathogenic) means a known disease-causing mutation was identified. This is the clearest outcome and triggers the most specific medical recommendations.
A less straightforward result is a “variant of uncertain significance,” meaning the lab found a genetic change but doesn’t yet know whether it causes disease. Current guidelines recommend that medical decisions for these results be based on your personal and family history, not the uncertain finding itself. In practice, this means your screening schedule and surgical options should look the same as someone who tested negative. The variant may be reclassified over time as more data becomes available, so your genetic counselor will typically follow up periodically.
A negative result doesn’t always mean zero risk. If a known mutation runs in your family and you don’t carry it, that’s genuinely reassuring. But if no family mutation was identified to begin with, a negative result is less definitive, and your doctor may still recommend enhanced screening based on family history alone.
How Screening Schedules Change
One of the most immediate changes after a hereditary diagnosis is a shift in how often and how thoroughly you’re screened. For carriers of BRCA1 or BRCA2 mutations, for example, screening typically includes regular breast MRIs and mammograms, plus transvaginal ultrasounds to watch for ovarian cancer. These happen more frequently and start at younger ages than standard screening recommendations for the general population.
For Lynch syndrome, which raises the risk of colorectal, endometrial, and other cancers, colonoscopies are generally recommended every one to two years. Some care plans also include endometrial biopsies. Research has found that people who receive colonoscopy and endometrial biopsy together report less pain and greater convenience than those who schedule them separately.
Your provider will build a personalized surveillance plan based on the specific mutation, your age, and your family’s cancer history. This plan replaces the general-population screening guidelines you would have followed otherwise.
Preventive Surgeries and Other Interventions
For certain hereditary conditions, preventive (prophylactic) surgery significantly reduces cancer risk. BRCA1/2 carriers may be offered preventive mastectomy or removal of the ovaries and fallopian tubes. For Lynch syndrome, preventive removal of the uterus or ovaries is recommended by roughly 64% of major clinical institutions, though practices vary by provider and specialty.
These are not emergency decisions. Most people have months or even years to weigh the options, gather second opinions, and plan around life circumstances. Preventive medication is another option for some conditions, either as an alternative to surgery or as a bridge while you decide. Your care team will walk through the risk reduction numbers for each approach so you can make an informed choice.
It’s worth knowing that the specialty of your doctor can influence what’s recommended. Research has shown that family medicine physicians are less likely to recommend preventive mastectomy (32%) compared to gynecologists (89% for breast MRI recommendations alone). If you feel your options aren’t being fully explored, asking for a referral to a genetics-focused specialist or a high-risk clinic is reasonable.
Telling Your Family and Cascade Testing
A hereditary diagnosis doesn’t just affect you. Your children, siblings, and parents are the most likely to carry the same genetic change, and the CDC recommends starting with these first-degree relatives when sharing results. This process is called cascade testing: informing family members about the condition, then having them tested.
How you share is up to you. Some people have direct conversations; others write letters. Sample letters are available for common hereditary conditions like hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia. Your genetic counselor can help you plan what to say and what information to include. Providing a copy of your genetic test report to family members helps them get tested faster, since the lab already knows which mutation to look for.
If a close relative can’t or won’t be tested, it’s appropriate to move to more distant relatives like aunts, uncles, and cousins. Genetic testing for adult-onset conditions is generally not performed on children, so testing in younger family members typically waits until they’re adults. One emotional complexity: family members who test negative sometimes experience guilt that they were spared while a sibling or parent was not. This is common and worth acknowledging openly.
Emotional Impact and Support
The personal and permanent nature of genetic information triggers a range of emotions that can catch people off guard. Guilt, fear, helplessness, and anger are all documented responses. Some people feel “broken” or interpret the diagnosis as something they can’t fight. Parents who learn their child carries a hereditary condition often experience grief, confusion, and self-blame.
These reactions are normal, not signs of weakness. Genetic counselors, social workers, and psychologists who specialize in genetics can help you process the diagnosis and think clearly about next steps. Support groups are particularly valuable because they connect you with people navigating the same decisions. Organizations like the Genetic Alliance (geneticalliance.org) and the National Organization for Rare Diseases (rarediseases.org) maintain directories of condition-specific groups.
Family Planning Options
If you’re considering having children, a hereditary diagnosis opens up specific reproductive options. Preimplantation genetic testing (PGT-M) allows embryos created through IVF to be screened for the specific mutation you carry before transfer. This applies to a wide range of inherited conditions, including autosomal dominant conditions like Huntington disease and cancer predisposition syndromes, autosomal recessive conditions like cystic fibrosis and sickle cell anemia, and X-linked conditions like hemophilia.
PGT-M requires IVF, which adds cost and time, but it gives carriers the option to significantly reduce the chance of passing on the condition. Prenatal testing during pregnancy (through amniocentesis or chorionic villus sampling) is another path. A genetic counselor can walk you through the logistics, success rates, and emotional considerations of each approach.
Insurance and Legal Protections
In the United States, the Genetic Information Nondiscrimination Act (GINA) prohibits health insurance companies from using genetic test results to deny coverage, set premiums, or apply pre-existing condition exclusions. Health plans also cannot require you to undergo genetic testing or collect your genetic information for underwriting purposes. Your genetic data is treated as protected health information under HIPAA.
GINA also bars employers from discriminating based on genetic information, covering hiring, firing, and terms of employment.
The critical gap: GINA does not cover life insurance, long-term care insurance, or disability insurance. No federal law prevents these insurers from using genetic test results in their decisions, and state laws vary widely. Vermont bars use of genetic test results by life insurers; other states only protect against discrimination for specific conditions like sickle cell trait; some simply require informed consent. Because of this gap, some genetic counselors suggest that people considering testing look into purchasing life and long-term care policies beforehand. Research has found that carriers of genes associated with conditions like Alzheimer’s disease are two to three times more likely to purchase long-term care insurance, which signals how real this concern is in practice.
What the Long Term Looks Like
Living with a hereditary diagnosis is not a single event but an ongoing relationship with your healthcare team. Screening schedules will be revisited as you age or as guidelines are updated. If you initially chose surveillance over preventive surgery, that decision can be revisited at any point. New family members will reach the age where testing becomes appropriate. And as genetic science advances, variants of uncertain significance may be reclassified, potentially changing your risk profile or your relatives’ results.
Most people find that the first few months after diagnosis are the hardest, when everything is new and decisions feel urgent. With time, the surveillance appointments become routine, family conversations get easier, and the diagnosis becomes one part of your health picture rather than the whole thing.